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ABSTRACT
Background Excimer laser coronary atherectomy 
(ELCA) can be used as an adjunctive percutaneous 
coronary intervention treatment for challenging, 
heavily calcified lesions. Although previous studies 
have documented high rates of complication and 
restenosis, these predate the introduction of the 
smaller 0.9 mm laser catheter. As the coronary 
complexity has increased, there has been a renewed 
interest in the ELCA. This study investigates the 
indications, procedural characteristics, complications 
and outcomes of ELCA in a contemporary coronary 
interventional practice.
Methods This single- centre study retrospectively 
analysed 50 patients treated with ELCA between 
January 2013 and January 2019.
Results Patients had a mean age of 67.9±11.4 
years with a male predominance (65.3%). 25 (50%) 
cases were performed in patients with stable angina. 
Failure to deliver the smallest available balloon/
microcatheter was the most frequent indication 
in 32 (64%) cases for ELCA use. 30 (60%) of the 
procedures were performed via radial access. The 0.9 
mm X-80 catheter was used in 41 (82%) of cases, 
delivering on average 9000±3929 pulses. ELCA- 
related complications included 2 coronary dissections 
and 1 perforation, all of which were covered with 
stents. No major complications could be directly 
attributed to the use of ELCA. There was one death 
and one case of stent thrombosis within 30 days of 
the procedure.
Conclusion ELCA can be performed safely via the 
radial approach with a 0.9 mm catheter with a high 
success rate by suitably trained operators. The low 
procedure- related complications with contemporary 
techniques make this a very useful tool for complex 
coronary interventions, especially for difficult to dilate 
lesions and chronic total occlusion vessels.
INTRODUCTION
Percutaneous coronary intervention (PCI) in 
patients with heavily calcified vessels is chal-
lenging. Severely calcified lesions account for 
up to 12% of patients undergoing coronary 
angiography1 and can prevent the crossing 
of balloons and even wires. Even if the lesion 
can be crossed with a wire, calcified or heavily 
fibrotic plaques may resist high- pressure non- 
compliant balloon inflations and cutting 
balloons. Attempting stent implantation 
within such lesions risk stent malapposi-
tion, underdeployment and increase risk of 
coronary dissection, perforation and stent 
Key questions
What is already known about this subject?
 ► Coronary laser atherectomy is a useful but un-
derused treatment modality in treatment of calcified 
difficult to cross lesions.
 ► There have been mixed earlier reports of success 
with this modality and relatively high procedural 
complications mostly with the bulky 1.4 mm laser 
catheter.
What does this study add?
 ► Our work shows that laser atherectomy via radial 
approach using 0.9 mm laser catheter is safe and 
convenient with good periprocedural outcomes.
How might this impact on clinical practice?
 ► These results are expected to encourage other cen-
tres involved in complex coronary intervention to 
take up coronary laser atherectomy more frequently 
in calcified, difficult to dilate lesions and chronic to-
tal occlusions.
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thrombosis. Specialised techniques and equipment are 
therefore required for such cases.
Atheroablation by excimer laser coronary atherectomy 
(ELCA) can be helpful in these circumstances. Excimer 
lasers use a mixture of rare gas and halogen to generate 
brief pulses of high- frequency ultraviolet (UV) light. 
The UV laser can disrupt hard atherosclerotic plaque 
through several mechanisms, including breaking molec-
ular bonds (photochemical), plaque cell rupture by 
heat generated at the catheter tip (photothermal) and 
disruption of intravascular material as vapour bubbles 
rapidly expand and implode (photomechanical).2 The 
fragments released are small (<10 µm) and thus do not 
obstruct the coronary microcirculation.3 The short wave-
length (308 nm) ensures minimal penetration of thermal 
energy beyond the intended target.
Compared with rotational atherectomy (RA), excimer 
catheters offer unique advantages including a short 
monorail segment, easing delivery over a standard 0.014” 
guidewire. Additionally, the most widely used 0.9 mm 
X-80 catheter is deliverable via a 6 Fr guide catheter, 
allowing ELCA to be performed via the radial approach. 
However, severely calcified plaques may require treat-
ment with both ELCA and RA in combination, referred 
to as a ‘RASER’ procedure.4
Laser atherectomy has been used as an adjunct to 
percutaneous coronary intervention since the early 
1980s.5 Early studies have documented high complica-
tion rates and restenosis.6 However, these studies predate 
the introduction of the smaller 0.9 mm catheter, which 
is now the most frequently used laser catheter for coro-
naries.7 Although the efficacy of ELCA has been assessed 
in a variety of clinical cohorts, there is a paucity of clin-
ical outcome data in a real- world mixture of patients 
presenting with and without acute myocardial infarc-
tion. In this study, we present indications, procedural 
characteristics, complications and outcomes of ELCA 
in a contemporary coronary interventional practice in a 
single large quaternary UK hospital over 6 years.
Table 1 Baseline data
Variable Mean (±SD) number (%)
Age, years 67.9 (±11.4)
Gender
  Male 32 (65.3%)
  Female 17 (34.7%)
BMI, kg/m2 29.1 (±5.8)
Previous CVA 2 (4.1%)
Peripheral vascular disease 4 (8.2%)
Non- cardiac surgery 2 (4.1%)
Previous MI 23 (46.9%)
Previous CABG 11 (22.4%)
Previous PCI 24 (29%)
Diabetes
  Not diabetic 27 (55.1)
  Diet controlled 1 (2)
  Oral medicine 12 (24.5)
  Insulin dependent 9 (18.4%)
Clinical syndrome











  Elective 23 (46%)
  Urgent 19 (38%)
  Emergency 8 (16%)
LV function
  Good (EF >50%) 31 (63.3)
  Moderate (EF 30%–50%) 8 (16.3)
  Poor (EF <30%) 4 (8.2)
  Unknown 6 (12.2)
Diagnostic devices
  None 38 (76%)
  IVUS/OCT 7 (14%)
  Pressure wire 2 (4%)
Procedural indications
Heavily calcified lesion 22 (44%)
CTO (failure to cross) 10 (20%)
High thrombus burden 11 (22%)
In- stent restenosis 7 (14%)
6 Fr guide catheter 41 (82%)
Continued
Variable Mean (±SD) number (%)
Arterial access
Radial (right/left) 30 (60%)
Femoral 16 (32%)
Combined (radial/femoral) 4 (8%)
Glycoprotein IIb/IIIa (eptifibatide) 8 (16%)
BMI, body mass index; CABG, coronary artery bypass grafting; 
CTO, chronic total occlusion; EF, ejection fraction; IVUS, 
intravascular ultrasound; LAD, left anterior descending artery; 
LCX, left cercumflex artery; LMS, left main stem; LV, left ventricle; 
MI, myocardial infarction; NSTEMI, non- ST- elevation myocardial 
infarction; OCT, optical coherence tomography; PCI, percutaneous 
coronary intervention; RCA, right coronary artery; STEMI, ST- 




















Fifty consecutive patients treated with ELCA from 1 
January 2013 to 31 January 2019 at the Queen Elizabeth 
Hospital, Birmingham, UK. Patients were identified 
using a prospectively maintained British Cardiovascular 
Interventional Society database.
As it was an all comers cohort, the indications ranged 
from elective PCI in the setting of stable angina to emer-
gency acute coronary syndromes with cardiogenic shock 
without any exclusion criteria. Laser was used if the lesion 
was angiographically assessed as heavily calcified and 
the inability of the smallest balloon or microcatheter to 
cross the lesion. For those lesions that were assessed with 
intravascular ultrasound or optical coherence tomog-
raphy, laser was used if the imaging suggested a very high 
thrombus burden or in calcified lesions a ≥270 degree 
of calcium arc, with ≥0.5 mm thickness and ≥40 mm of 
length of calcified lesion.
Outcomes
Immediate procedural success was defined as thrombol-
ysis in myocardial infarction (TIMI) III flow in the target 
vessel with <50% pre- angioplasty luminal stenosis. Major 
adverse cardiac and cerebrovascular event (MACCE) 
were defined as all- cause death, myocardial infarction 
or stroke and was recorded during hospital stay and at 
30- day follow- up.
ELCA procedure details
The excimer laser system (Spectranetics CVX-300) 
uses xenon chloride medium to generate UV light and 
produces a monochromatic single wavelength—308 nm 
fluence of 20–80 mJ/mm2 and pulse repetition rate of 
40–80 Hz. Vascular access was obtained using 6 or 7 Fr 
sheaths in the radial or femoral arteries. In some cases, 
both radial and femoral access were required. The laser 
catheter used was of 0.9 mm or 1.4 mm in diameter. Saline 
flush and bathe technique was used to clear the blood and 
dye during delivery of the therapy and the catheter was 
advanced in small increments with 10 s bursts of lasing.
RESULTS
Baseline characteristics
Patients had a mean age of 67.9±11.4 years and a male 
preponderance 32/50 (64%). The majority of patients 
(72%) had previous revascularisation with either PCI or 
coronary artery bypass grafting. Twelve (24%) patients 
had adjuvant coronary fractional flow reserve/coronary 
imaging at the same time. Twenty- three (46%) patients 
were treated electively and 8 (16%) patients were treated 
as emergencies for ST- elevation MI, among whom 3 (6%) 
patients were in cardiogenic shock. Laser atherectomy was 
used as an adjuvant to coronary RA in 11 (22%) cases and 
thrombus aspiration was performed in 6 (12%) patients. 
Glycoprotein IIb/IIIa inhibitor was used in eight (16%) 
cases. Thirty (60%) cases were performed by radial (left/
right) approach without the need to change the access 
site. Only 16 (32%) cases were performed via the femoral 
approach and a further 4 (8%) used both radial and 
femoral approach. One of the main indications of ELCA 
was the failure of balloon tracking due to a calcified 
lesion or chronic total occlusion (CTO) occurred, which 
was seen in 32 (64%) cases (table 1).
Laser technical data
The majority of cases (82%) were performed using the 
0.9 mm diameter ELCA catheter. A frequency of 80 Hz 
was used in 18 (36%) cases and 40–80 Hz in another 12 
(24%) cases. The data were not available for the rest 
of the cases. The mean number of laser pulses were 
9000±3929 (table 2).
Procedure outcomes
There were no periprocedural complications in 46 (92%) 
patients (figure 1). Laser atherectomy was successful in 
crossing all uncrossable lesions where the smallest balloon 
or microcatheter could not cross. A coronary perfora-
tion occurred in one case and was treated by a covered 
stent. The perforation was attributed to use of RA. Two 
cases of coronary dissection were seen and were treated 
successfully with a drug- eluting stent. These complica-
tions were not directly attributable to the use of ELCA. 
Table 2 Procedural data
Variable Mean (±SD) number (%) Variable Mean (±SD) number (%)
Size of laser catheter (mm) Fluence
  0.9 41 (82 %) 80 16 (32%)
  1.4 3 (6%) 40–80 13 (26%)
  Unknown 6 (12%) Unknown 21 (42%)
Frequency (Hz) Adjunctive rotational atherectomy 11 (22%)
  80 18 (36%) Size of burr
  40–80 12 (24%) 1.25 mm 4 (8%)
  Unknown 20 (40%) 1.5–2 mm 5 (10%)
  Number of pulses 9000 (±3929) >2 mm 2 (4%)
Hz, Hertz; mm, Millimeter.
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One death occurred during the procedure in a patient 
with cardiogenic shock in the context of a late presenting 
MI. Apart from one mortality, all patients had immediate 
procedural success with <50% residual stenosis and TIMI 
III flow in the target vessel. The mean stented segment 
length was 41 mm (SD 9 mm) and diameter was 3.1 mm 
(SD 4.2 mm). Within 30 days of the procedure, there was 
one transient ischaemic attack and one stent thrombosis 
leading to MI and both these patients made full recovery 
(table 3).
DISCUSSION
This study documents the 6- year experience of a single 
large quaternary centre using ELCA to treat non- crossable, 
heavily calcified coronary artery lesions. Presence of CTO 
and very calcified lesion was the main indication in about 
two- thirds of the cases in our cohort. The results from 
this retrospective study found that ELCA was associated 
with high rates of procedural success and low rates of 
periprocedural complications. The majority of PCI proce-
dures are performed via the radial artery and on finding 
non- crossable lesions, ELCA can be performed without 
the need for changing access site. While previous studies 
report up to 48%4 transradial ELCA, in this study 60% of 
cases were performed via the transradial approach alone 
without compromising success or complication rate.
This study demonstrates a low rate of coronary dissec-
tion compared with other studies. In trials excluding 
patients with acute MI, the rate of angiographic dissection 
following ELCA use has been reported as up to 13%.8 In 
another study of 151 post- MI patients treated with ELCA,9 
major dissection occurred in 5% of cases, compared 
with only 2% in the present study. Other studies have 
corroborated that low rates of coronary dissection can 
be achieved. The multicentre CORAL trial demonstrated 
that the procedural success of ELCA in the treatment of 
patients with saphenous vein grafts was lower (82%) than 
comparative studies in native coronary vessels, however, 
the rate of major dissection was just under 1% and lower 
30- day MACE as compared with control population from 
theSaphenous vein graft Angioplasty Free of Emboli 
Randomized (SAFER) trial.10
With an ageing population, heavily calcified coro-
nary lesions and in- stent restenosis (ISR) are likely to 
be encountered with increasing frequency. ELCA is 
expected to become more widely adopted over time. The 
use of ELCA to treat patients with ISR has been assessed 
in several studies. Applying laser to five types of stainless- 
steel coronary stents did not impact stent endurance or 
release significant particulate matter. ELCA in the setting 
of ISR has similar rates of procedural success, complica-
tions and long- term clinical outcomes as balloon angio-
plasty alone,11 and RA.12 The combination of ELCA and 
balloon angioplasty produces greater stent expansion 
than balloon angioplasty alone.13
While RA remains the main treatment modality for 
heavily calcified lesions, it relies on a 0.009- inch RotaWire 
be advanced distal to the lesion. Case series have demon-
strated that RASER can facilitate revascularisation where 
the RotaWire could not traverse the lesion.4 In this study, 
ELCA was combined with RA in 22% of cases, which is 
higher than previous work by Badr et al.14
Limitations
ELCA is a specialised coronary adjunctive treatment 
which is performed only in a relatively small number of 
centres with expertise. This retrospective study is there-
fore limited by the small number of ELCA procedures 
performed despite assessing a 6- year timeframe. Further-
more, while 30- day MACCE data are presented, long- 
term data have not been compiled. Another limitation 
has been the relatively low use of intracoronary imaging 
used. This could be explained by the presence of some 
cases with acute MI and high thrombus burden in which 
flow restoration and clinical stability was the first priority 
of management. Moreover, the accepted standard of use 
of intracoronary imaging in the highly calcified vessels 
was not as widespread in the earlier half of the dataset.
CONCLUSIONS
ELCA can be performed safely via the radial approach in 
most patients with a 0.9 mm catheter with a high success 
rate. The low procedure- related complications with 
contemporary techniques make this a very useful tool for 
complex coronary interventions, especially for difficult to 
dilate lesions or CTO vessels.
Figure 1 Immediate periprocedural complications while the 
patient was in the cardiac catheter lab.
Table 3 30- Day MACCE (for death, myocardial infarction 
and stroke/TIA)
Variable N (%)
No complication 47 (94%)
Death 1 (2%)
Myocardial infarction (subacute stent thrombosis) 1 (2%)
TIA 1 (2%)
MACCE, major adverse cardiac and cerebrovascular event; TIA, 
transient ischaemic attack.
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